Rigel Pharmaceuticals secures rights to develop and market VEPPANU under new agreement
Rigel Pharmaceuticals announced the completion of a global license agreement to develop, manufacture, and commercialize VEPPANU, also known as vepdegestrant. The agreement marks a significant ...